WebThe National Library of Medicine (NLM), on the NIH campus in Bethesda, Maryland, is the world's largest biomedical library and the developer of electronic information services that delivers data to millions of scientists, health professionals and members of the public around the globe, every day. WebCytarabine (ARA-C) IV: <100mg/m2 Dasatinib (Sprycel) oral Decitabine (Dacogen) IV Denileukin diftitox (Ontak) IV Dexrazoxane (Totect, Zinecard) IV Erlotinib (Tarceva) oral Everolimus (Afinitor, Zortress) oral Fludarabine (Fludara) IV Hydroxyurea (Hydrea) oral Imatinib (Gleevec) oral Interferon alpha (IFN-alfa, Intron A) IV: ≤5 million IU/m2
CYCLOPHOSPHAMIDE injection, for intravenous use
WebThe aims of trial NHL-BFM 90 for patients (pts) suffering from B-cell neoplasms are to prove whether: 1. Treatment for pts with complete resection can be reduced from 3 to 2 therapy courses; 2. Results for pts of stage III with large abdominal tumors can be improved by high dose (HD) chemotherapy; 3. WebOct 1, 2003 · A series of 2-halo-2′-halo-2′-arabinosyladenine analogues including clofarabine (Cl-F-ara-A; 2-chloro-2′-fluoro-deoxy-9-β-D-arabinofuranosyladenine) was developed as a rational extension of the experience with fludarabine and chlorodeoxyadenosine, in an attempt to improve the drug efficacy and minimize extramedullary toxicities 12 ().The 2 … earthquake tazz viper 212cc chipper shredder
Effectiveness of modified hyper-CVAD chemotherapy regimen in …
WebCyclophosphamide ( CP ), also known as cytophosphane among other names, [3] is a medication used as chemotherapy and to suppress the immune system. [4] As … WebNov 28, 2024 · Cyclophosphamide oral is taken by mouth. Cyclophosphamide injection is given as an infusion into a vein. A healthcare provider will give you this injection. Drink plenty of liquids each day to prevent harmful effects on your bladder. Cyclophosphamide affects your immune system. You may get infections more easily, even serious or fatal … WebOct 1, 1998 · The patients in the cyclosporine arm had a significantly better 2-year disease-free survival and overall survival than patients in the tacrolimus arm, 50.4% versus 40.5% ( P = .01) and 57.2% versus 46.9% ( P = .02), respectively. ct neck annotated radio